companyprofile
Actions
Nahdi Medical Co.
- Main Market
- Consumer Staples Distribution & Retail
Stats Overview
-
Prev. Close 112.80
-
Open 112.80
-
High 113.60
-
Low 112.00
-
No. of Trades 2,030
-
Avg. Trade size* 74
-
Volume Traded 150,110
-
Value Traded (^) 16,941,013.00
Performance
- *Average Trade Size = Cumulative / # of Trades
- **52 Week Price Change = (Current Price - Price year ago) / Price year ago x 100
- Historical prices & volume traded data are adjusted to account for all corporate actions.
- MO: Market Order
Trade Updates
Last Trade
Best Bid
Best Offer
52 WEEK
PERFORMANCE
Compare Selected
Select a Maximum of 5 Companies
LoginPortletPopupv2
Actions
AddtoWatchlistv2
Actions
AnnouncmentandCorporateAction
Actions
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Announcements
Corporate Actions
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Dividends
| Announced Date | Eligibility Date | Distribution Date | Distribution Way | Dividend Amount |
|---|---|---|---|---|
| 10/03/2025 | 17/03/2025 | 25/03/2025 | Account Transfer | ^3.00 |
| 31/07/2024 | 11/08/2024 | 25/08/2024 | Account Transfer | ^2.50 |
| 17/03/2024 | 21/03/2024 | 02/04/2024 | Account Transfer | ^3.00 |
| 02/08/2023 | 10/08/2023 | 24/08/2023 | Account Transfer | ^2.50 |
| 20/03/2023 | 28/03/2023 | 10/04/2023 | Account Transfer | ^3.00 |
CompanyProfilev2Financials
Actions
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Financials
- FINANCIAL INFORMATION
- FINANCIAL STATEMENTS AND REPORTS
- Annually
- Quarterly
| Balance Sheet | 2024-12-31 | 2023-12-31 | ||
|---|---|---|---|---|
| Total Assets |
6,173,349
|
5,371,327
|
- | - |
| Total Liabilities |
3,587,246
|
2,908,571
|
- | - |
| Total Shareholders Equity (After Deducting the Minority Equity) |
2,586,103
|
2,462,756
|
- | - |
| Total Liabilities and Shareholders Equity |
6,173,349
|
5,371,327
|
- | - |
| Statement of Income | 2024-12-31 | 2023-12-31 | ||
| Total Revenue (Sales/Operating) |
9,446,420
|
8,713,676
|
- | - |
| Net Profit (Loss) before Zakat and Tax |
834,544
|
944,246
|
- | - |
| Zakat and Income Tax |
-13,820
|
-51,628
|
- | - |
| Net Profit (Loss) after Zakat and Tax |
820,724
|
892,618
|
- | - |
| Total Comprehensive Income |
838,347
|
934,372
|
- | - |
| Profit (Loss) per Share |
6.31
|
6.87
|
- | - |
| Cash Flows | 2024-12-31 | 2023-12-31 | ||
| Net Cash From Operating Activities |
1,491,354
|
1,368,728
|
- | - |
| Net Cash From Investing Activities |
-328,015
|
-384,257
|
- | - |
| Net Cash From Financing Activities |
-1,116,961
|
-1,150,674
|
- | - |
| Cash and Cash Equivalents, Beginning of the Period |
909,662
|
1,076,312
|
- | - |
| Cash and Cash Equivalents, End of the Period |
956,810
|
909,662
|
- | - |
| All Figures in | Thousands | Thousands | ||
| All Currency In | ^ | ^ | ||
| Last Update Date | 2025-03-13 | 2024-03-18 |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.
| Balance Sheet | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-09-30 |
|---|---|---|---|---|
| Total Assets |
5,914,058
|
5,759,088
|
5,675,553
|
5,130,752
|
| Total Liabilities |
3,504,961
|
3,181,231
|
3,358,560
|
2,854,915
|
| Total Shareholders Equity (After Deducting the Minority Equity) |
2,409,097
|
2,577,856
|
2,316,994
|
2,275,837
|
| Total Liabilities and Shareholders Equity |
5,914,058
|
5,759,088
|
5,675,553
|
5,130,752
|
| Statement of Income | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-09-30 |
| Total Revenue (Sales/Operating) |
2,353,252
|
2,472,664
|
2,257,497
|
2,162,900
|
| Net Profit (Loss) before Zakat and Tax |
159,305
|
260,607
|
242,339
|
222,600
|
| Zakat and Income Tax |
22,883
|
-12,871
|
-9,389
|
-9,795
|
| Net Profit (Loss) after Zakat and Tax |
182,188
|
247,736
|
232,950
|
212,805
|
| Total Comprehensive Income |
156,241
|
260,863
|
244,238
|
223,117
|
| Profit (Loss) per Share |
1.4
|
1.91
|
1.79
|
1.64
|
| Cash Flows | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-09-30 |
| Net Cash From Operating Activities |
1,129,198
|
569,518
|
462,428
|
1,149,994
|
| Net Cash From Investing Activities |
-266,087
|
-189,890
|
-100,566
|
-255,971
|
| Net Cash From Financing Activities |
-1,025,947
|
-561,705
|
-502,362
|
-1,054,267
|
| Cash and Cash Equivalents, Beginning of the Period |
909,662
|
909,662
|
909,662
|
1,076,312
|
| Cash and Cash Equivalents, End of the Period |
747,650
|
728,404
|
769,940
|
916,447
|
| All Figures in | Thousands | Thousands | Thousands | Thousands |
| All Currency In | ^ | ^ | ^ | ^ |
| Last Update Date | 2024-10-31 | 2024-08-04 | 2024-05-08 | 2023-11-05 |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Company Profile
Company overview
In accordance with its Bylaws, the Company''s activities revolve around Manufacturing industries, Wholesale and retail trade and repair of motor vehicles and motorcycles, Transportation and storage, Telecommunication & Information Technology, Financial and insurance activities, Professional, scientific, and technical activities, Administrative and support service activities, Public administration and defense; compulsory social security, Human health and social work activities.
Company History
Nahdi Medical Company was established as a single shareholder company in 1986 by Abdullah Amer bin Munif Al-Nahdi on 11/10/1406H (corresponding to 18/06/1986G). On 03/04/1424H (corresponding to 03/06/2003G), Abdullah Amer bin Munif Al-Nahdi Establishment was converted from a single shareholder company to a limited liability company by the name of Abdullah Amer bin Munif Al-Nahdi & Partners Company for Pharmacies and Medical Equipment with the participation of the Tawjeeh Services & Commercial Investments Company, and a capital of fifty million (50,000,000) Saudi Riyals divided into fifty thousand (50,000) fully paid in-kind shares of equal value of one thousand Saudi Riyals (SAR 1,000) per share. On 02/06/1425H (corresponding to 19/07/2004G), the Company''s name was changed to Nahdi Medical Company. On 20/04/1429H (corresponding to 27/04/2008G), Abdullah Amer Munif Al-Nahdi assigned his entire twenty-five thousand (25,000) shares to Al-Nahdi Holding Company Limited. On 29/07/1439H (corresponding to 15/04/2018G), Youssef Mayoud Al-Harthi, who is a licensed pharmacist, entered the Company as a business partner. On 27/02/1443H (corresponding to 04/10/2021G), the Company was converted from a limited liability company to a closed joint-stock company with a capital of one billion three hundred million (SAR 1,300,000,000) Saudi Riyals, divided into one hundred and thirty million (130,000,000) fully paid Ordinary Shares with a nominal value of ten (SAR 10) Saudi Riyals per share.
Company Bylaws
Equity Profile
- Authorized Capital (^) 1,300,000,000
- Issued Shares 130,000,000
- Paid Capital (^) 1,300,000,000
- Par Value/Share 10
- Paid Up Value/Share 10
Last Update :2022-03-22
Investment limits
There are no investment limits on the company shares as per the amended Rules for Qualified Foreign Financial Institutions Investments in Listed Securities and Instructions for the Foreign Strategic Investors Ownership in Listed Companies based on company bylaw and the issued instructions by the related regulators and supervisory authorities
- Company Details
- BOARD OF DIRECTORS AND SENIOR EXECUTIVES INFORMATION
Investor Relations
Contact Name:
Investor Relations
Company Address:
Ibrg Alraghamah District Jeddah 21484,BOX 17129 Kingdom of Saudi Arabia
Contact Details:
Telephone:
0126535353
Fax
: 0126074399
Email
: IR@nahdi.sa
Company Website:
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of these disclosures, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of these disclosures, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.
- ${title}${badge}